| Basics |
Atai Life Sciences N.V.
ATA Inc is a computer-based testing service provider. The company offers testing systems such as test development, test delivery, and data management. It also provides test-based training, education programs, and test preparation courses to individuals.
|
| IPO Date: |
June 18, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.57B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.15 | 3.78%
|
| Avg Daily Range (30 D): |
$0.14 | 2.96%
|
| Avg Daily Range (90 D): |
$0.16 | 3.23%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.57M |
| Avg Daily Volume (30 D): |
4.33M |
| Avg Daily Volume (90 D): |
5.52M |
| Trade Size |
| Avg Trade Size (Sh.): |
218 |
| Avg Trade Size (Sh.) (30 D): |
211 |
| Avg Trade Size (Sh.) (90 D): |
240 |
| Institutional Trades |
| Total Inst.Trades: |
190 |
| Avg Inst. Trade: |
$1.33M |
| Avg Inst. Trade (30 D): |
$1.35M |
| Avg Inst. Trade (90 D): |
$1.08M |
| Avg Inst. Trade Volume: |
.29M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.29M |
| Avg Closing Trade (30 D): |
$1.12M |
| Avg Closing Trade (90 D): |
$1.02M |
| Avg Closing Volume: |
346.41K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.83
|
$-.28
|
$-.14
|
|
Diluted EPS
|
$-.83
|
$-.28
|
$-.14
|
|
Revenue
|
$ 3.02M
|
$ .75M
|
$ .72M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -154.3M
|
$ -61.1M
|
$ -27.75M
|
|
Operating Income / Loss
|
$ -104.34M
|
$ -28.44M
|
$ -25.27M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -14.45M
|
$ -31.07M
|
$ 3.45M
|
|
PE Ratio
|
|
|
|
|
|
|
